• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL2400412 静注人免疫球蛋白(pH4) Human Immunoglobulin(pH4) Injection Biological Products(3.2) New Drug Application 2024-06-26 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2400143 狂犬病人免疫球蛋白 human rabies immunoglobulin Injection Biological Products(3.4) Supplementary Application 2024-06-04 Hualan Biological Engineering Chongqing Co Ltd view
CYSB2400114 静注人免疫球蛋白(pH4) Human Immunoglobulin(pH4) Injection Biological Products Supplementary Application 2024-05-15 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2400097 静注人免疫球蛋白(pH4) Human Immunoglobulin(pH4) Injection Biological Products(原15) Supplementary Application 2024-04-25 Green Cross China Biological Products Co Ltd view
CYSB2400098 静注人免疫球蛋白(pH4) Human Immunoglobulin(pH4) Injection Biological Products(原15) Supplementary Application 2024-04-25 Green Cross China Biological Products Co Ltd view
CYSB2400096 静注人免疫球蛋白(pH4) Human Immunoglobulin(pH4) Injection Biological Products(原15) Supplementary Application 2024-04-25 Green Cross China Biological Products Co Ltd view
CYSB2400092 破伤风人免疫球蛋白 human tetanus immunoglobulin Injection Biological Products(原15) Supplementary Application 2024-04-18 Hualan Biological Engineering Inc view
CXSL2400234 静注人免疫球蛋白(pH4) Human Immunoglobulin(pH4) Injection Biological Products(3.4) New Drug Application 2024-04-16 Sichuan Yuanda Shuyang Pharmaceutical Co Ltd view
CYSB2400083 人免疫球蛋白 human immunoglobulin Injection Biological Products(原15) Supplementary Application 2024-03-29 Hualan Biological Engineering Inc view
CYSB2400084 人免疫球蛋白 human immunoglobulin Injection Biological Products(原15) Supplementary Application 2024-03-29 Hualan Biological Engineering Inc view
CYSB2400071 乙型肝炎人免疫球蛋白 Human Hepatitis B Immunoglobulin Injection Biological Products(原15) Supplementary Application 2024-03-15 Hualan Biological Engineering Inc view
CYSB2400072 乙型肝炎人免疫球蛋白 Human Hepatitis B Immunoglobulin Injection Biological Products(原15) Supplementary Application 2024-03-15 Hualan Biological Engineering Inc view
CYSB2400062 静注人免疫球蛋白(pH4) Human Immunoglobulin(pH4) Injection Biological Products(原15) Supplementary Application 2024-03-05 China Resources Boya Bio-pharmaceutical Group Co Ltd view
CYSB2400061 静注人免疫球蛋白(pH4) Human Immunoglobulin(pH4) Injection Biological Products(原15) Supplementary Application 2024-03-01 China National Pharmaceutical Group Guizhou Biopharmaceutical Co Ltd view
CYSB2400058 静注人免疫球蛋白(pH4) Human Immunoglobulin(pH4) Injection Biological Products(原15) Supplementary Application 2024-03-01 China National Pharmaceutical Group Guizhou Biopharmaceutical Co Ltd view
CYSB2400036 狂犬病人免疫球蛋白 human rabies immunoglobulin Injection Biological Products(原15) Supplementary Application 2024-02-07 Hualan Biological Engineering Inc view
CYSB2400019 狂犬病人免疫球蛋白 human rabies immunoglobulin Injection Biological Products(3.4) Supplementary Application 2024-01-18 Hualan Biological Engineering Chongqing Co Ltd view
CYSB2400018 狂犬病人免疫球蛋白 human rabies immunoglobulin Injection Biological Products(3.4) Supplementary Application 2024-01-18 Hualan Biological Engineering Chongqing Co Ltd view
CYSB2300180 破伤风人免疫球蛋白 human tetanus immunoglobulin Injection Biological Products Supplementary Application 2023-10-11 Shanxi Kangbao Biological Product Co Ltd view
CYSB2300152 破伤风人免疫球蛋白 human tetanus immunoglobulin Injection Biological Products Supplementary Application 2023-08-19 Chengdu Rongsheng Pharmaceuticals Co Ltd view